Abstract Introduction: Eating disorders (EDs), particularly Anorexia Nervosa (AN), remain one of the most severe and treatment-resistant eating disorders, with…
Abstract Background: Extrapyramidal symptoms affect an average of 37%, with a maximum prevalence of 71.4%, among individuals on antipsychotics. About…
Abstract Treatment-resistant schizophrenia (TRS) affects up to 30% of individuals with schizophrenia who fail to respond to standard antipsychotics. This…
Abstract Background: Artistic creativity is often observed in individuals with schizoaffective disorder, bipolar type, while medication adherence can be compromised…
Abstract Schizophrenia (SCZ) is a complex psychiatric disorder with positive, negative, and cognitive symptoms that cause long-term functional impairment. Despite…
Abstract Introduction: The endocannabinoid (eCB) system disruption has been suggested to underpin the development of psychosis, fueling the search for…
Abstract The pharmacological interventions available for individuals in the early stages of psychosis are extremely limited. For those at clinical…
Abstract Schizophrenia typically emerges during adolescence, with progression from an ultra-high risk state (UHR) to the first episode of psychosis…
Abstract Antipsychotic (AP) medications are the mainstay for the treatment of schizophrenia spectrum disorders (SSD), but their efficacy is unpredictable…
Abstract Psychotic disorders such as schizophrenia are heterogeneous and often debilitating conditions that contribute substantially to the global burden of…